Assessment of the Clinical Condition and Way of Nutrition Patients Before and After Sleeve Gastrectomy

Obesity Clinical Trial

Official title:

Assessment of Intake of Energy and Selected Nutrients, Nutritional Status, Body Composition and Biochemical Parameters of Obese Patients Before and After Bariatric Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05667558
• Other study ID #: N/ST/MN/18/001/3316
• Status: Completed
• Start date: November 30, 2017
• Est. completion date: December 31, 2018

Study information

• Verified date: November 2022
• Source: Medical University of Bialystok
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Conservative treatment of patients with morbid obesity is inefficient, which is why surgical treatment is necessary. Although bariatric treatment is associated with the occurrence of complications resulting from the procedure or from nutritional insufficiencies, it leads to significant body mass reduction and metabolic improvement of obese patients.

The aim of the study was to determine the clinical condition of obese patients after laparoscopic sleeve gastrectomy ( LSG) in terms of nutritional status, metabolic disorders and way of nutrition.

The study conduced 4 visits: preliminary visit (1 day before the surgery) and control visits (1, 3 and 6 months after the surgery). Based on the inclusion and exclusion criteria the observational study was conducted among 30 participants (15 women and 15 men).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: December 31, 2018
• Est. primary completion date: December 31, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion criteria

• women and men aged 18-64

• BMI = 40 kg/m2 or BMI = 35 kg/m2 with comorbidities such as type II diabetes (T2DM), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease

Exclusion Criteria:

• pregnancy

• gastrointestinal cancers

• cardiorespiratory failure

Related Conditions & MeSH terms

• Obesity

Locations

Country	Name	City	State
Poland	Medical University of Bialystok	Bialystok

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Bialystok

Country where clinical trial is conducted

Poland, 

References & Publications (12)

Al-Mutawa A, Anderson AK, Alsabah S, Al-Mutawa M. Nutritional Status of Bariatric Surgery Candidates. Nutrients. 2018 Jan 11;10(1):67. doi: 10.3390/nu10010067. — View Citation

Batar N, Pulat Demir H, Bayram HM. Assessment of nutritional status, body composition and blood biochemical parameters of patients following sleeve gastrectomy: 6 months follow up. Clin Nutr ESPEN. 2021 Jun;43:184-190. doi: 10.1016/j.clnesp.2021.04.016. Epub 2021 Apr 27. — View Citation

Bower G, Toma T, Harling L, Jiao LR, Efthimiou E, Darzi A, Athanasiou T, Ashrafian H. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. Obes Surg. 2015 Dec;25(12):2280-9. doi: 10.1007/s11695-015-1691-x. — View Citation

Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014 Mar;149(3):275-87. doi: 10.1001/jamasurg.2013.3654. — View Citation

Dulloo AG, Jacquet J, Miles-Chan JL, Schutz Y. Passive and active roles of fat-free mass in the control of energy intake and body composition regulation. Eur J Clin Nutr. 2017 Mar;71(3):353-357. doi: 10.1038/ejcn.2016.256. Epub 2016 Dec 14. — View Citation

Friedrich AE, Damms-Machado A, Meile T, Scheuing N, Stingel K, Basrai M, Kuper MA, Kramer KM, Konigsrainer A, Bischoff SC. Laparoscopic sleeve gastrectomy compared to a multidisciplinary weight loss program for obesity--effects on body composition and protein status. Obes Surg. 2013 Dec;23(12):1957-65. doi: 10.1007/s11695-013-1036-6. — View Citation

Fuchs T, Loureiro M, Both GH, Skraba HH, Costa-Casagrande TA. THE ROLE OF THE SLEEVE GASTRECTOMY AND THE MANAGEMENT OF TYPE 2 DIABETES. Arq Bras Cir Dig. 2017 Oct-Dec;30(4):283-286. doi: 10.1590/0102-6720201700040013. — View Citation

Hopkins M, Finlayson G, Duarte C, Whybrow S, Ritz P, Horgan GW, Blundell JE, Stubbs RJ. Modelling the associations between fat-free mass, resting metabolic rate and energy intake in the context of total energy balance. Int J Obes (Lond). 2016 Feb;40(2):312-8. doi: 10.1038/ijo.2015.155. Epub 2015 Aug 17. — View Citation

Milone M, Lupoli R, Maietta P, Di Minno A, Bianco P, Ambrosino P, Coretti G, Milone F, Di Minno MN, Musella M. Lipid profile changes in patients undergoing bariatric surgery: a comparative study between sleeve gastrectomy and mini-gastric bypass. Int J Surg. 2015 Feb;14:28-32. doi: 10.1016/j.ijsu.2014.12.025. Epub 2015 Jan 7. — View Citation

Sherf Dagan S, Tovim TB, Keidar A, Raziel A, Shibolet O, Zelber-Sagi S. Inadequate protein intake after laparoscopic sleeve gastrectomy surgery is associated with a greater fat free mass loss. Surg Obes Relat Dis. 2017 Jan;13(1):101-109. doi: 10.1016/j.soard.2016.05.026. Epub 2016 Jun 2. — View Citation

Sherf Dagan S, Zelber-Sagi S, Webb M, Keidar A, Raziel A, Sakran N, Goitein D, Shibolet O. Nutritional Status Prior to Laparoscopic Sleeve Gastrectomy Surgery. Obes Surg. 2016 Sep;26(9):2119-2126. doi: 10.1007/s11695-016-2064-9. Erratum In: Obes Surg. 2017 Jul 5;: — View Citation

Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013 Dec;23(12):1994-2003. doi: 10.1007/s11695-013-1030-z. — View Citation

* Note: There are 12 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in anthropometric measurements during the 6 months after surgery	Body weight in kilograms was measured using a scale with stadiometer. Body height in meters was measured using a scale with stadiometer. Body weight and height were used to calculate BMI (Body Mass Index) in kilograms divided by square metres.; Hip circumference in centimeters was measured at the greater trochanters at the widest part of the hips. Waist circumference in centimeters was measured at the uppermost lateral border of the hip crest.	before and 1,3 and 6 months after LSG
Primary	Changes in percentage of excess weight loss during the 6 months after surgery	Percentage of excess weight loss (%EWL) was calculated using the formula: %EWL = (preoperative weight - current weight)/(preoperative weight - ideal weight) × 100.; Ideal body weight was calculated using Lorentz formula.	1, 3 and 6 months after LSG
Primary	Changes in body composition during the 6 months after surgery	Body composition was assessed four times (before and 1,3 and 6 months after LSG). Body composition parameters (fat mass in kilograms, percentage of body fat, fat free mass in kilograms, percentage of fat free mass, total body water in liters, percentage of total body water) was determined using the bioelectrical impedance method (BioScan 920-2 body composition analyzer, Maltron International Ltd., United Kingdom)	before and 1,3 and 6 months after LSG
Primary	Changes in energy and selected nutrients intake during the 6 months after surgery	The intake of energy and selected nutrients was assessed four times (before and 1,3 and 6 months after LSG). A 3-day nutrition interview was collected. The supply of energy, protein, fat (including fatty acids), carbohydrates, dietary fibre, vitamins and minerals in the usual diet was assessed.	before and 1,3 and 6 months after LSG
Primary	Changes in blood biochemical parameters of patients during the 6 months after surgery.	The biochemical parameters of the patient's blood were assessed four times (before and 1,3 and 6 months after LSG). Laboratory tests were performer to determine the following serum levels: fasting glucose, fasting insulin,total cholesterol, LDL cholesterol fraction, HDL cholesterol fraction, triglycerides and aminotransferases: alanine (ALT) and aspartate (AST), complete blood count.; The HOMA-IR (homeostasis model assessment of insulin resistance) index was calculated according to the formula: [fasting insulin (mIU/l) x fasting glucose (mg/dl)] / 405	before and 1,3 and 6 months after LSG